13.03.2013 Views

2012 Promega catalogue

2012 Promega catalogue

2012 Promega catalogue

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Cell Signaling<br />

Anti-ACTIVE ® Caspase-3 pAb<br />

Product Size Cat.# Price ($)<br />

Anti-ACTIVE ® Caspase-3 pAb 50 µl G7481 500.00<br />

For Research Use Only. Not for Use in Diagnostic Procedures.<br />

Description: Anti-ACTIVE ® Caspase-3 pAb is intended for use as a marker<br />

of apoptosis; it specifically stains apoptotic cells without staining nonapoptotic<br />

cells. Includes sufficient antibody to perform 125 immunocytochemical assays<br />

(100μl/assay) at a 1:250 dilution.<br />

Features:<br />

• Immunogen: Peptide derived from the p17 fragment of caspase-3 and<br />

having sequence homology in human, mouse, rat and hamster.<br />

• Antibody Form: Affinity-purified rabbit IgG; supplied in Dulbecco’s PBS.<br />

• Specificity: Specifically recognizes the cleaved active form of caspase-3<br />

in human, rat and mouse.<br />

Storage Conditions: Store at –20°C.<br />

Protocol Part#<br />

Anti-ACTIVE ® Caspase-3 pAb Protocol 9PIG748<br />

Demonstration of Anti-ACTIVE ® Caspase-3 pAb positive cells in<br />

postnatal day 0 (P0) mouse brain paraffin-embedded sections. Panel<br />

A. Three Anti-ACTIVE ® Caspase-3 pAb-positive cells (colored arrows). Panel<br />

B. Corresponding DAPI-stained nuclei. Note the correspondence of Anti-<br />

ACTIVE ® Caspase-3 pAb label with the typical apoptotic, condensed nuclear<br />

morphology in Panel B. Protocols developed and performed at <strong>Promega</strong>.<br />

For complete and up-to-date product information visit: www.promega.com/catalog<br />

3158TB<br />

Anti-PARP p85 Fragment pAb<br />

Product Size Cat.# Price ($)<br />

Anti-PARP p85 Fragment pAb<br />

For Research Use Only. Not for Use in Diagnostic Procedures.<br />

50 µl G7341 539.00<br />

Description: Poly (ADP-ribose) polymerase (PARP), a nuclear enzyme involved<br />

in DNA repair, is a substrate for caspase-3 cleavage during apoptosis.<br />

Anti-PARP p85 Fragment pAb is a rabbit polyclonal antibody specific for the<br />

p85 fragment of PARP that results from caspase cleavage of the 116kDa<br />

intact molecule and thus provides an in situ marker for apoptosis. The antibody<br />

is affinity-purified using a peptide that corresponds to a region of the p85<br />

fragment of PARP. The PARP immunogen is a synthetic peptide, gly-val-aspglu-val-ala-lys<br />

(GVDEVAK), representing the N-terminus of the large C-terminal<br />

fragment of human PARP that results from caspase-3 cleavage. Each batch<br />

of antibody is quality assurance tested for use in immunostaining applications<br />

and contains sufficient antibody for 50 immunocytochemical reactions at the<br />

suggested working dilution of 1:100.<br />

Features:<br />

• Immunogen: N-terminal peptide from p85 fragment.<br />

• Antibody Form: Affinity-purified rabbit polyclonal antibody provided in<br />

Dulbecco’s PBS.<br />

• Specificity: Specifically detects PARP p85 fragment in human, rat and bovine<br />

cells and tissues. Does not recognize the 116kDa intact PARP protein.<br />

Storage Conditions: Store at –20°C.<br />

Protocol Part#<br />

Anti-PARP p85 Fragment pAb Technical Bulletin TB273<br />

Anti-PARP p85 Fragment pAb and TUNEL double-labeling of apoptotic<br />

Jurkat cells. Cells were labeled with the Anti-PARP p85 Fragment pAb<br />

(red) and the DeadEnd Fluorometric TUNEL System (Cat.# G3250;<br />

green). The colocalization of cleaved PARP in cells containing TUNEL-positive<br />

nuclei demonstrates that the Anti-PARP p85 Fragment pAb specifically labels<br />

apoptotic cells. Protocols developed and performed at <strong>Promega</strong>.<br />

2734TA08_9A<br />

33<br />

2<br />

Cell Health Assays<br />

Section<br />

Contents<br />

Table of<br />

Contents

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!